Virtual reality goggles could replace extra painkillers during kidney surgery
NCT ID NCT07538687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using virtual reality (VR) during arteriovenous fistula surgery—a procedure for dialysis patients—can lower pain, anxiety, and the need for anesthesia. About 64 adults with end-stage kidney disease will be randomly assigned to receive VR or standard care while awake during the operation. The goal is to see if VR makes the experience less stressful and improves patient comfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 64 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged ≥18 years scheduled for elective arteriovenous fistula (AVF) creation surgery. * Diagnosed with End-Stage Renal Disease (ESRD) and indicated for hemodialysis access. * Able to provide informed consent and understand study procedures. * Medically stable and cleared for surgery by the anesthesia and surgical teams. * Able to wear a virtual reality headset (e.g., no severe claustrophobia or facial injuries preventing use). Exclusion Criteria: * Patients with a history of seizure disorders or epilepsy triggered by visual stimuli. * Severe motion sickness, vertigo, or vestibular disorders that may be exacerbated by virtual reality. * Significant cognitive impairment or inability to understand instructions or complete questionnaires. * Facial or cranial abnormalities or injuries that prevent proper fitting of the VR headset. * Patients requiring general anesthesia.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End stage renal disease on dialysis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a special filter help dialysis remove toxins it usually misses?
- Can hidden heart rhythms explain dialysis risks?
- Can a Brain-Targeting drug silence the relentless itch of dialysis?
- Can a new graft keep dialysis access working longer?
- Could a Starch-Based drug clean toxins from dialysis Patients' blood?
- Can a diabetes drug boost dialysis efficiency for kidney patients?